Press Releases

Cure Alzheimer's Fund's Genome Project Reveals Map of Alzheimer's Genome, Identifies 4 New Genes

Posted: Oct. 29, 2008

Four novel genes that may significantly increase the risk of the most common form of late-onset Alzheimer’s have been identified by researchers at Massachusetts General Hospital and Harvard Medical School, as reported in the November 7th issue of American Journal of Human Genetics. The findings, part of a larger “Alzheimer’s Genome Project” (AGP) established three years ago to identify the full set of Alzheimer’s disease genetic risk factors, may lead to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease. These new therapies would differ from current treatments that only address the symptoms of the disease.

Cure Alzheimer's Fund co-sponsors Tomorrow's Leader in Alzheimer's Disease Research Award

Posted: Sep. 24, 2008

The award co-sponsored by the Cure Alzheimer's Fund and the Alzheimer's Association honors the legacies of two pioneering Alzheimer researchers, George G. Glenner and Leon J. Thal.  The two $100,000 grants will be made to early career researchers to inspire and enable innovative research which leads to effective therapies for Alzheimer's Disease.

Tanzi Discusses "Alzheimer's Genome Project" at International Alzheimer's Conference

Posted: Jul. 22, 2008

Map of Alzheimer’s Genes May Lead to Novel Therapies

Dr. Rudolph Tanzi Speaks at International Conference on Alzheimer’s

Breakthrough genetic research to map all the genes connected to Alzheimer’s, which could lead to more aggressive treatment and a potential cure for the disease, was the focus of a presentation by leading Alzheimer’s researcher Dr. Rudolph Tanzi at the International Conference on Alzheimer’s Disease (ICAD) in Chicago.

Tanzi Testifies Before Senate on Latest Progress of Fast-Track Effort to Map Genes for Alzheimer's

Posted: May 13, 2008
Dr. Tanzi Testifies Before Senate

Washington, May 14, 2008 – Mapping the sequence of the genes susceptible to Alzheimer’s disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimer’s early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, told the Senate Special Committee on Aging at a hearing today on the disease.

Scaling Heights to Cure Alzheimer's

Posted: Aug. 15, 2007

Mountaineer to Raise Awarness, Research Funding for Alzheimer's on Road Back to Everest

Boston - Embarking on a yearlong challenge that he hopes will end at the top of Mt. Everest, mountain climber Alan Arnette will take on a greater challenge along his journey, raising money for research and public awareness of Alzheimer’s disease.

Coalition of Alzheimer's Organizations Announces New "Genius Grant" for Younger Researchers

Posted: Jun. 14, 2007

In an effort to support the next generation of leading Alzheimer's researchers, the Cure Alzheimer's Fund has joined with the Alzheimer's Association and the Lou Ruvo Brain Institute to create and fund a new "genius grant" for young Alzheimer's researchers.

Cure Alzheimer's Fund's Dr.Tanzi Briefs Congress on Research Progress, Rep. Markey Praises Fund

Posted: Mar. 29, 2007

Washington – With more than 5 million Americans now living with Alzheimer’s disease, a 10 percent increase since 2002, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s in hopes of leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease.

Cure Alzheimer's Fund's Dr. Rudy Tanzi Honored as Top Researcher by the Alzheimer's Association

Posted: Mar. 28, 2007

Washington – In recognition of his groundbreaking genetic research and outstanding leadership and commitment to finding a cure and better treatment for Alzheimer’s disease, Dr. Rudolph Tanzi received the 2007 Ronald and Nancy Reagan Award at the Alzheimer’s Association’s National Gala this week.

Massachusetts General Hospital Honors Cure Alzheimer's Fund with First-Ever Philanthropic Award

Posted: Mar. 4, 2007

Boston – Massachusetts General Hospital (MassGeneral) has honored Cure Alzheimer’s FundTM for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer's disease. The first annual Award for “Philanthropic Innovation and Investment” was presented to the Fund by MassGeneral’s Institute for Neurodegenerative Disease, at a ceremony at Massachusetts General Hospital on Friday, March 2.

New Web-based Alzheimer's Disease Genetic Research Clearinghouse Launched

Posted: Feb. 27, 2007

First-of-its-Kind Online Resource ( Offers Researchers an Extensive Database of Studies on the Genes Associated with Alzheimer's Risk

Boston, MA – AlzGene, a web-based clearinghouse for researchers working to unlock the genetic makeup of Alzheimer’s Disease, has been launched as a way to gather and analyze studies by and for investigators around the world. The project aims to bring clarity to the increasingly prolific and confusing field of Alzheimer’s genetics research.